- Home
- AFRI vs ATAI Comparison
AFRI vs ATAI Comparison
Compare AFRI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFRI
- ATAI
- Stock Information
- Founded
- AFRI 1943
- ATAI 2018
- Country
- AFRI Gibraltar
- ATAI Germany
- Employees
- AFRI N/A
- ATAI N/A
- Industry
- AFRI Packaged Foods
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- AFRI Consumer Staples
- ATAI Health Care
- Exchange
- AFRI Nasdaq
- ATAI Nasdaq
- Market Cap
- AFRI 275.5M
- ATAI 222.3M
- IPO Year
- AFRI N/A
- ATAI 2021
- Fundamental
- Price
- AFRI $10.06
- ATAI $1.78
- Analyst Decision
- AFRI
- ATAI Strong Buy
- Analyst Count
- AFRI 0
- ATAI 4
- Target Price
- AFRI N/A
- ATAI $9.00
- AVG Volume (30 Days)
- AFRI 10.7K
- ATAI 1.6M
- Earning Date
- AFRI 01-14-2025
- ATAI 11-13-2024
- Dividend Yield
- AFRI N/A
- ATAI N/A
- EPS Growth
- AFRI N/A
- ATAI N/A
- EPS
- AFRI N/A
- ATAI N/A
- Revenue
- AFRI $305,476,000.00
- ATAI $331,000.00
- Revenue This Year
- AFRI N/A
- ATAI $80.07
- Revenue Next Year
- AFRI N/A
- ATAI N/A
- P/E Ratio
- AFRI N/A
- ATAI N/A
- Revenue Growth
- AFRI 5.42
- ATAI N/A
- 52 Week Low
- AFRI $9.63
- ATAI $1.03
- 52 Week High
- AFRI $12.00
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- AFRI 45.28
- ATAI 69.91
- Support Level
- AFRI $10.01
- ATAI $1.21
- Resistance Level
- AFRI $10.36
- ATAI $1.38
- Average True Range (ATR)
- AFRI 0.28
- ATAI 0.12
- MACD
- AFRI -0.00
- ATAI 0.06
- Stochastic Oscillator
- AFRI 27.37
- ATAI 83.00
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.